| 1 |
30409294 | Triggering TLR3 pathway promotes tumor growth and cisplatin resistance in head and neck cancer cells. | 2018 Nov |
2 |
| 2 |
27470347 | Interferon β improves the efficacy of low dose cisplatin by inhibiting NF-κB/p-Akt signaling on HeLa cells. | 2016 Aug |
1 |
| 3 |
25158919 | Synergistic anti-carcinogenic effect of interferon-β with cisplatin on human breast adenocarcinoma MDA MB231 cells. | 2014 Nov |
3 |
| 4 |
23600838 | The effects of chemotherapeutic drugs on human monocyte-derived dendritic cell differentiation and antigen presentation. | 2013 Jun |
3 |
| 5 |
23977343 | Interferon-β produces synergistic combinatory anti-tumor effects with cisplatin or pemetrexed on mesothelioma cells. | 2013 |
2 |
| 6 |
22396773 | Chemotherapeutics and radiation stimulate MHC class I expression through elevated interferon-beta signaling in breast cancer cells. | 2012 |
1 |
| 7 |
19267105 | Disappearance of gadolinium enhancement in a chemoresistant astrocytoma of the tectum after high-dose interferon beta. | 2008 Nov-Dec |
1 |
| 8 |
14654475 | Interferon-beta is more potent than interferon-alpha in inhibition of human hepatocellular carcinoma cell growth when used alone and in combination with anticancer drugs. | 2003 Dec |
1 |
| 9 |
12396726 | Cytotoxicity of combinations of IFN-beta and chemotherapeutic drugs. | 2002 Aug |
1 |
| 10 |
2513306 | Enhancement of cytotoxicity of cisplatin in vitro by recombinant human tumor necrosis factor and/or recombinant human interferon-alpha, -beta and -gamma. | 1989 Sep |
1 |